LTGHY Stock Life Healthcare Group Holdings (LTGHY, $2.81) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 11, 2025

GET DAILY SIGNALS

Get AI intraday signals

LTGHY - Life Healthcare Group Holdings Ltd

MACD signal

View

Odds of UP Trend

Price: $2.81

Daily change: +$0.03 (+1.08%)

Daily volume: 26.1K

Capitalization: $1B

Industry: Hospital/Nursing Management

This is a Bullish indicator signaling LTGHY's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 54 similar cases where LTGHY's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

LTGHY sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for LTGHY moved above the 200-day moving average on October 08, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 12, 2025. You may want to consider a long position or call options on LTGHY as a result. In of 120 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LTGHY just turned positive on November 11, 2025. Looking at past instances where LTGHY's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

LTGHY moved above its 50-day moving average on November 10, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LTGHY advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LTGHY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LTGHY broke above its upper Bollinger Band on October 28, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for LTGHY entered a downward trend on November 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.982) is normal, around the industry mean (8.474). P/E Ratio (10.508) is within average values for comparable stocks, (113.087). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.302). Dividend Yield (0.041) settles around the average of (0.038) among similar stocks. P/S Ratio (0.662) is also within normal values, averaging (1.518).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LTGHY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.